نتائج البحث - "Kioa L. Wijnsma"

المساهمون: Groningen Institute for Organ Transplantation (GIOT), Groningen Kidney Center (GKC), Nephrology, AII - Infectious diseases, AII - Inflammatory diseases, APH - Aging & Later Life, Paediatric Nephrology, ARD - Amsterdam Reproduction and Development, AII - Amsterdam institute for Infection and Immunity, Pediatrics, ACS - Microcirculation, Amsterdam Reproduction & Development (AR&D)

المصدر: Kidney International Reports, 8, 715-726
Kidney International Reports, 8(4), 715-726. ELSEVIER SCIENCE INC
the Dutch aHUS Working Group 2023, ' Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation ', Kidney International Reports, vol. 8, no. 4, pp. 715-726 . https://doi.org/10.1016/j.ekir.2023.01.016Test
Kidney Int Rep
Kidney International Reports, 8, 4, pp. 715-726
Kidney International Reports, 8(4), 715-726. Elsevier Inc.

مصطلحات موضوعية: All institutes and research themes of the Radboud University Medical Center, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], Nephrology, Clinical Research, atypical hemolytic uremic syndrome, kidney transplantation, eculizumab, Renal disorders Radboud Institute for Health Sciences [Radboudumc 11], thrombotic microangiopathy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7865deffdd1dcfa0e4e75f5c72df14cfTest
http://hdl.handle.net/2066/292465Test

4

Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C

المؤلفون: Bryan van den Broek, Michiel van der Flier, Nicole C.A.J. van de Kar, Jack F.M. Wetzels, Marien I. de Jonge, Ronald de Groot, Kioa L. Wijnsma, Jeroen D. Langereis

المصدر: Kidney International, 101, 1293-1295
Kidney International, 101, 6, pp. 1293-1295

مصطلحات موضوعية: Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], Nephrology, lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4], Humans, Renal disorders Radboud Institute for Health Sciences [Radboudumc 11], Neisseria meningitidis, Serogroup B, Antibodies, Monoclonal, Humanized, Serogroup, Atypical Hemolytic Uremic Syndrome

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b66d2c4706f610dc068bf2248b4f1a2eTest
http://hdl.handle.net/2066/251614Test

5

Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab

المؤلفون: Jack F.M. Wetzels, Dirk Jan A.R. Moes, Saskia E M Schols, Rob ter Heine, Saskia Langemeijer, Nicole C. A. J. van de Kar, Kioa L. Wijnsma, Elena B. Volokhina, Lambertus P. van den Heuvel, Roger J. M. Brüggemann

المصدر: Clinical Pharmacokinetics, 58, 859-874
Clinical Pharmacokinetics, 58, 7, pp. 859-874
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 58(7), 859-874

مصطلحات موضوعية: Drug, Thrombotic microangiopathy, media_common.quotation_subject, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Review Article, 030204 cardiovascular system & hematology, Pharmacology, ANTIBODY-MEDIATED REJECTION, DOUBLE-BLIND, 03 medical and health sciences, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Pharmacokinetics, PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, Atypical hemolytic uremic syndrome, medicine, Pharmacology (medical), Pharmacology & Pharmacy, MYASTHENIA-GRAVIS, media_common, Science & Technology, medicine.diagnostic_test, business.industry, LONG-TERM SAFETY, Eculizumab, EFFICACY, medicine.disease, 3. Good health, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Therapeutic drug monitoring, THROMBOTIC MICROANGIOPATHY, SYNDROME REQUIREMENT, 030220 oncology & carcinogenesis, Pharmacodynamics, Paroxysmal nocturnal hemoglobinuria, HEMOLYTIC-UREMIC SYNDROME, Renal disorders Radboud Institute for Health Sciences [Radboudumc 11], business, Life Sciences & Biomedicine, COMPLEMENT INHIBITOR ECULIZUMAB, medicine.drug

وصف الملف: application/pdf; Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac348e08e03be9e5ba7a9073f83de3eeTest
https://hdl.handle.net/2066/204830Test

6

Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use

المؤلفون: Jack F.M. Wetzels, Kioa L. Wijnsma, Caroline Duineveld, Nicole C. A. J. van de Kar

المصدر: Pediatric Nephrology (Berlin, Germany)

مصطلحات موضوعية: Graft Rejection, Nephrology, medicine.medical_specialty, Time Factors, Thrombotic microangiopathy, Treatment protocol, Atypical hemolytic uremic syndrome, 030232 urology & nephrology, Review, 030204 cardiovascular system & hematology, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Secondary Prevention, medicine, Humans, Intensive care medicine, Dose-Response Relationship, Drug, business.industry, Treatment regimen, Complement C5, Correction, Restrictive treatment regimen, Eculizumab, medicine.disease, Kidney Transplantation, Personalized medicine, Transplant Recipients, 3. Good health, Complement Inactivating Agents, Practice Guidelines as Topic, Pediatrics, Perinatology and Child Health, Disease Progression, Feasibility Studies, Kidney Failure, Chronic, Drug Monitoring, business, medicine.drug, Cohort study, Prophylactic treatment

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f84ade6305cdf1a9884c861fb1dd248Test
https://doi.org/10.1007/s00467-018-4091-3Test

7

Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient

المؤلفون: Lambertus P. van den Heuvel, Jack F.M. Wetzels, Caroline Duineveld, Nicole C. A. J. van de Kar, Elena B. Volokhina, Mendy Ter Avest, Rob ter Heine, Romy N. Bouwmeester, Kioa L. Wijnsma

المصدر: Frontiers in Immunology, Vol 11 (2021)
Frontiers in Immunology, 11
Frontiers in Immunology

مصطلحات موضوعية: 0301 basic medicine, lcsh:Immunologic diseases. Allergy, medicine.medical_specialty, therapeutic drug monitoring, Immunology, 030232 urology & nephrology, Case Report, Gastroenterology, 03 medical and health sciences, aHUS, 0302 clinical medicine, Pharmacotherapy, All institutes and research themes of the Radboud University Medical Center, Internal medicine, Atypical hemolytic uremic syndrome, medicine, Immunology and Allergy, pharmacokinetic, Proteinuria, medicine.diagnostic_test, business.industry, atypical hemolytic uremic syndrome, Eculizumab, medicine.disease, Regimen, 030104 developmental biology, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Therapeutic drug monitoring, eculizumab, Age of onset, medicine.symptom, Renal disorders Radboud Institute for Health Sciences [Radboudumc 11], proteinuria, business, lcsh:RC581-607, Kidney disease, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f18573eb3e2104198ce9c2f922660f28Test
https://www.frontiersin.org/articles/10.3389/fimmu.2020.612706/fullTest

8

Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome

المؤلفون: Thea J A M van der Velden, Kioa L. Wijnsma, Susan T. Veissi, Nicole C. A. J. van de Kar, Elena B. Volokhina, Sem de Wijs, L.P.W.J. van den Heuvel, Frank A. D. T. G. Wagener

المصدر: Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, 11

مصطلحات موضوعية: 0301 basic medicine, Male, hemopexin, Apoptosis, medicine.disease_cause, Pathogenesis, chemistry.chemical_compound, 0302 clinical medicine, Immunology and Allergy, Child, heme, Heme, chemistry.chemical_classification, Shiga-Toxigenic Escherichia coli, STEC-HUS, Hemopexin, Hemolysis, Protein Transport, Phenotype, Reconstructive and regenerative medicine Radboud Institute for Molecular Life Sciences [Radboudumc 10], 030220 oncology & carcinogenesis, Child, Preschool, Female, Disease Susceptibility, Oxidation-Reduction, lcsh:Immunologic diseases. Allergy, medicine.medical_specialty, Thrombotic microangiopathy, Immunology, HO-1, Thromboplastin, 03 medical and health sciences, Tissue factor, All institutes and research themes of the Radboud University Medical Center, Stress, Physiological, Internal medicine, medicine, Humans, TMA, Reactive oxygen species, Endothelial Cells, Infant, medicine.disease, 030104 developmental biology, Endocrinology, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], chemistry, Hemolytic-Uremic Syndrome, Reactive Oxygen Species, lcsh:RC581-607, Oxidative stress, Biomarkers, Heme Oxygenase-1

وصف الملف: Electronic-eCollection; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d02c72f5ef50d4d07976fa35d1dc44Test
https://www.frontiersin.org/articles/10.3389/fimmu.2020.547406/fullTest

9

Author's Reply to Liu et al.: 'Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab'

المؤلفون: Jack F.M. Wetzels, Rob ter Heine, Roger J. M. Brüggemann, Kioa L. Wijnsma, Nicole C. A. J. van de Kar

المصدر: Clinical Pharmacokinetics, 59, 1645-1646
Clinical Pharmacokinetics, 59, 12, pp. 1645-1646

مصطلحات موضوعية: Pharmacology, medicine.medical_specialty, business.industry, Pharmacology toxicology, MEDLINE, Eculizumab, Antibodies, Monoclonal, Humanized, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Pharmacotherapy, Pharmacokinetics, medicine, Humans, Pharmacology (medical), Renal disorders Radboud Institute for Health Sciences [Radboudumc 11], Intensive care medicine, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29c6870f479bce5105e74ae927c60214Test
http://hdl.handle.net/2066/229067Test

10

Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire)

المؤلفون: Xana van Jaarsveld, Jack F.M. Wetzels, Rémy L M Mostard, Marlies S. Wijsenbeek, Adrienne H. Rotteveel, Nelleke C. Tak, M. Gelens, Merel Kimman, Carmen D. Dirksen, Marjolein Storm, Nicole C. A. J. van de Kar, Kioa L. Wijnsma

المساهمون: Pulmonary Medicine, Neurology, Erasmus MC other, MUMC+: KIO Kemta (9), MUMC+: MA Nefrologie (9), Health Services Research, RS: CAPHRI - R2 - Creating Value-Based Health Care

المصدر: The Patient
Patient 2008, 10(5), 629-642. Springer Science+Business Media
Patient-Patient Centered Outcomes Research, 10, 629-642
Patient-Patient Centered Outcomes Research, 10, 5, pp. 629-642
The Patient: patient-centered outcomes research, 10(5), 629-642. Adis International Ltd

مصطلحات موضوعية: Male, Nursing (miscellaneous), Orphan Drug Production, PREFERENCES, COVERAGE DECISIONS, Health administration, 0302 clinical medicine, ECULIZUMAB, Surveys and Questionnaires, Content validity, 030212 general & internal medicine, Original Research Article, Atypical Hemolytic Uremic Syndrome, Netherlands, CLINICAL-PRACTICE GUIDELINE, 030503 health policy & services, Patient Preference, Middle Aged, 3. Good health, Patient Satisfaction, Female, REPORTED OUTCOME MEASURES, 0305 other medical science, medicine.medical_specialty, PSYCHOMETRIC VALIDATION, Psychometrics, Pyridones, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Interviews as Topic, 03 medical and health sciences, Patient satisfaction, Patient experience, medicine, Humans, Face validity, Aged, Retrospective Studies, Health economics, business.industry, Reproducibility of Results, Usability, CARE, Focus group, Idiopathic Pulmonary Fibrosis, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], Physical therapy, Quality of Life, HEMOLYTIC-UREMIC SYNDROME, IDIOPATHIC PULMONARY-FIBROSIS, Renal disorders Radboud Institute for Health Sciences [Radboudumc 11], business, HEALTH TECHNOLOGY-ASSESSMENT

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1428ba8a5937de7bbd6641cb7645c17fTest
https://doi.org/10.1007/s40271-017-0234-zTest

تنقيح النتائج